Equities research analysts expect Hill-Rom Holdings Inc (NYSE:HRC) to report $1.28 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Hill-Rom Holdings’ earnings, with estimates ranging from $1.27 to $1.29. Hill-Rom Holdings posted earnings of $1.18 per share in the same quarter last year, which would suggest a positive year over year growth rate of 8.5%. The firm is expected to announce its next earnings report on Thursday, November 2nd.

According to Zacks, analysts expect that Hill-Rom Holdings will report full year earnings of $3.82 per share for the current fiscal year, with EPS estimates ranging from $3.81 to $3.83. For the next financial year, analysts anticipate that the firm will report earnings of $4.30 per share, with EPS estimates ranging from $4.20 to $4.38. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Hill-Rom Holdings.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The business had revenue of $689.10 million for the quarter, compared to the consensus estimate of $695.50 million. During the same period last year, the business posted $0.81 EPS. The business’s revenue was up 5.1% compared to the same quarter last year.

HRC has been the topic of several analyst reports. Zacks Investment Research cut Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. ValuEngine upgraded Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Barclays PLC increased their price objective on Hill-Rom Holdings from $80.00 to $86.00 and gave the company an “overweight” rating in a research note on Friday, June 9th. Finally, Cantor Fitzgerald initiated coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “neutral” rating and a $86.00 price objective on the stock. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $88.17.

COPYRIGHT VIOLATION NOTICE: This report was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.americanbankingnews.com/2017/09/09/1-28-eps-expected-for-hill-rom-holdings-inc-hrc-this-quarter.html.

Shares of Hill-Rom Holdings (NYSE:HRC) traded up 0.64% on Friday, hitting $77.42. The stock had a trading volume of 354,245 shares. The firm has a market cap of $5.10 billion, a price-to-earnings ratio of 45.12 and a beta of 1.21. The stock has a 50 day moving average of $76.07 and a 200 day moving average of $74.71. Hill-Rom Holdings has a 12-month low of $50.50 and a 12-month high of $84.65.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.93%. The ex-dividend date is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 41.62%.

Several hedge funds have recently modified their holdings of HRC. Strs Ohio purchased a new position in shares of Hill-Rom Holdings during the first quarter worth about $1,765,000. Russell Investments Group Ltd. grew its holdings in shares of Hill-Rom Holdings by 64.3% during the first quarter. Russell Investments Group Ltd. now owns 62,568 shares of the medical technology company’s stock worth $4,418,000 after purchasing an additional 24,477 shares during the last quarter. Oregon Public Employees Retirement Fund grew its holdings in shares of Hill-Rom Holdings by 1.5% during the first quarter. Oregon Public Employees Retirement Fund now owns 20,913 shares of the medical technology company’s stock worth $1,476,000 after purchasing an additional 300 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Hill-Rom Holdings by 6.9% during the first quarter. Wells Fargo & Company MN now owns 71,499 shares of the medical technology company’s stock worth $5,047,000 after purchasing an additional 4,619 shares during the last quarter. Finally, Canada Pension Plan Investment Board grew its holdings in shares of Hill-Rom Holdings by 457.1% during the first quarter. Canada Pension Plan Investment Board now owns 11,700 shares of the medical technology company’s stock worth $826,000 after purchasing an additional 9,600 shares during the last quarter. 82.31% of the stock is currently owned by institutional investors.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Get a free copy of the Zacks research report on Hill-Rom Holdings (HRC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.